| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | Feb 22, 2025 | Boerner Christopher S. CEO | Buy | Bristol Myers Squibb Co | BMY | $55.05 | $110,096 | +1.88% |
| Dec 05, 2023 | Dec 07, 2023 | Boerner Christopher S. CEO | Buy | Bristol Myers Squibb Co | BMY | $49.78 | $99,560 | +2.36% |
| Nov 28, 2023 | Nov 30, 2023 | Boerner Christopher S. CEO | Buy | Bristol Myers Squibb Co | BMY | $48.86 | $150,049 | +3.72% |
| Mar 14, 2022 | Mar 16, 2022 | Boerner Christopher S. EVP Chief Commercial Officer | Sell | Bristol Myers Squibb Co | BMY | $69.2 | $2M | -41.30% |
| Aug 24, 2014 | Aug 27, 2014 | Boerner Christopher S. EVP Comm | Sell | Seattle Genetics Inc /wa | SGEN | $43.55 | $54,349 | -1.70% |
| Feb 21, 2014 | Feb 25, 2014 | Boerner Christopher S. SVP Commercial | Sell | Seattle Genetics Inc /wa | SGEN | $54.98 | $79,825 | -3.06% |
| Aug 19, 2013 | Aug 22, 2013 | Boerner Christopher S. SVP Commercial | Sell | Seattle Genetics Inc /wa | SGEN | $40.91 | $9,246 | -0.47% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.